The approval means Implantica can begin launching the implant on the US market.
RefluxStop, which is already CE-marked, is used for the treatment of gastroesophageal reflux disease (GERD), which causes heartburn and acid reflux. The implant restores and maintains the natural anatomy of the gastroesophageal junction, without encircling or applying pressure on the food passageway.
BREAKING